Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03723005 · ClinicalTrials.gov registry record
A Light Emitting Diode (LED) Mattress for Phototherapy of Jaundiced Newborns
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 41
- Enrollment target
NCT03723005: Completed study, sponsored by Stanford University.
NCT03723005 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 41 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03723005 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 41 participants
- Enrollment target
Study Summary
The new investigational and FDA-approved device is named "SkyLife" and is a mattress, which uses blue LEDs as the light source similar to those used in the currently-used overhead blue LED panel devices.
Interventions
- DEVICE Neolight Phototherapy Mattress
- DEVICE Standard-of-Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2018-05-01 |
| Est. Completion | 2023-04-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03723005
The ClinicalTrials.gov registry entry for NCT03723005 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Neolight Phototherapy Mattress is the first listed.
NCT03723005 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03723005 about?
NCT03723005 is a clinical study titled "A Light Emitting Diode (LED) Mattress for Phototherapy of Jaundiced Newborns". The new investigational and FDA-approved device is named "SkyLife" and is a mattress, which uses blue LEDs as the light source similar to those used in the currently-used overhead blue LED panel devices.
What is the current status of trial NCT03723005?
This trial is currently completed. The enrollment target is 41 participants. The study started on 2018-05-01. Estimated completion is 2023-04-04.
What interventions are being tested in trial NCT03723005?
The interventions under investigation include: Neolight Phototherapy Mattress (DEVICE), Standard-of-Care (DEVICE).
Who is sponsoring clinical trial NCT03723005?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.